New Zealand markets closed

Actinogen Medical Limited (ATGGF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.01500.0000 (0.00%)
At close: 09:40AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Operating expenses
Research development
8,900
8,900
8,215
2,406
5,537
Selling general and administrative
6,568
6,568
4,558
3,111
2,213
Total operating expenses
15,873
15,873
13,173
5,904
8,912
Operating income or loss
-15,873
-15,873
-13,173
-5,904
-8,912
Interest expense
16.599
16.599
18.479
22.318
28.882
Total other income/expenses net
4,771
4,771
3,653
1,984
3,516
Income before tax
-10,752
-10,752
-9,497
-3,915
-5,331
Income tax expense
0
0
0
0
0
Income from continuing operations
-10,752
-10,752
-9,497
-3,915
-5,331
Net income
-10,752
-10,752
-9,497
-3,915
-5,331
Net income available to common shareholders
-10,752
-10,752
-9,497
-3,915
-5,331
Basic EPS
-0.01
-
-0.01
-0.00
-0.00
Diluted EPS
-0.01
-
-0.01
-0.00
-0.00
Basic average shares
1,875,607
-
1,787,680
1,462,925
1,187,695
Diluted average shares
1,875,607
-
1,787,680
1,462,925
1,187,695